Clinical Trial Update: An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating rivaroxaban with warfarin for prevention of stroke and non-CNS systemic embolism in patients with non-valvular atrial f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke
• Systemic Embolism

Drugs mentioned

• Warfarin (warfarin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Atrial Fibrillation, Stroke | Phase 3 | Status: COMPLETED | Results posted: 2012-07-17